COUGHLIN TIMOTHY 4
4 · Travere Therapeutics, Inc. · Filed May 10, 2024
Insider Transaction Report
Form 4
Coughlin Timothy P
Director
Transactions
- Award
Stock option (right to buy)
2024-05-08+19,500→ 19,500 totalExercise: $6.82From: 2025-05-08Exp: 2034-05-07→ Common Stock (19,500 underlying) - Award
Common Stock
2024-05-08+6,500→ 49,000 total
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.